Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients

Surg Oncol Clin N Am. 2006 Oct;15(4):751-64. doi: 10.1016/j.soc.2006.07.015.

Abstract

Because of the borderline location between the esophagus and stomach, many discrepancies exist in the current literature regarding the etiology, classification, and surgical treatment of adenocarcinoma arising at the esophagogastric junction. The classification of adenocarcinomas into three types, AGE type I, type II, and type III, shows marked differences between the tumor entities and is recommended for selection of a proper surgical approach. Complete tumor resection and adequate lymphadenectomy are recommended for a good, long-term prognosis. With better surgical management and standardized procedures, even the results in patients with more radical surgical approaches, the abdomino-thoracic esophagectomy improved.

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagectomy
  • Esophagogastric Junction / pathology
  • Esophagogastric Junction / surgery*
  • Female
  • Gastrectomy
  • Humans
  • Intestinal Neoplasms / pathology
  • Intestinal Neoplasms / surgery*
  • Lymph Node Excision
  • Lymph Nodes / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Stomach / pathology
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Survival Rate